Kestra Medical Director Elizabeth Kwo Receives RSU Award

What Happened
Elizabeth Kwo (listed on the filing as Kwo Elizabeth), a director of Kestra Medical Technologies, Ltd. (KMTS), received a grant of 7,217 restricted stock units (RSUs) on September 9, 2026. The filing reports the award with a per-share price of N/A; each RSU entitles the holder to one common share upon vesting. This was a compensation award (not a purchase or sale) and therefore reflects equity compensation rather than an open-market trade.

Key Details

• Transaction date: 2026-09-09; filing date: 2026-09-10 (filed within required Form 4 timing).
• Transaction type/code: A — Grant/Award (7,217 RSUs). Price shown as N/A.
• Vesting/conditions: RSUs vest on September 9, 2027, subject to continued service through that date (per footnote).
• Shares owned after transaction: Not reported in this filing.
• Footnote: Each RSU entitles the reporting person to receive one common share upon vesting.

Context
RSU grants are a common form of executive/director compensation and do not require an immediate cash outlay; they convert to actual shares only if and when they vest, which can dilute outstanding shares when settled. This award is informational about compensation and does not by itself indicate buying or selling sentiment.